SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Orphan drug CROs look to capitalize on influx of biotech cash

As small biotech companies continue to cash in on new investments, IPOs and increasing approval rates of orphan and rare disease drugs, CROs are cashing in too and helping the companies navigate the regulatory and clinical landscape.

Small CROs looking to gain from IPO cash

Veeva encouraged to tap CRO industry after inVentiv puts head in the cloud

Veeva Systems has reported a robust Q3 strengthened by increasing interest in its cloud-based clinical trial management software and a deal with inVentiv Health.

Analyst: Parexel book-to-bill worries will be short-lived

Last quarter’s disappointing book-to-bill ratio for Parexel, which sent the CRO’s shares down about 15% will be short term, according to an analyst.

Medidata: Prepare to embrace digital biomarkers in trials or lose competitiveness

The advent of Big Data in clinical trials will mean companies not using digital biomarkers are unlikely to exist by 2025, the President of cloud-based technology firm Medidata has warned.

AMRI re-opens troubled sterile injectable facility in New Mexico

AMRI’s Albuquerque, New Mexico sterile injectable facility has resumed full manufacturing operations following an environmental deviation. 

Spotlight

Trial transparency's impact opaque say drug and CRO industry experts at PCT in Barcelona

Trial transparency's impact opaque say drug and CRO industry experts at PCT in Barcelona

Making clinical trials more open has pros and cons for CROs and drugmakers according to experts from...

In-house manufacturing ‘trounces’ outsourcing spend, report finds

In-house manufacturing investments ‘trounce’ outsourcing spend, report finds

Biopharma companies are not likely to outsource a larger chunk of their manufacturing than they have in...

Top 7 CROs soon to exceed 50% market share, Parexel CFO says

Top 7 CROs soon to exceed 50% market share, Parexel CFO says

As PRA Health Services goes public this week, nearly all of the top CROs are now public...

China sets new requirements for hospitals running clinical trials

China sets new requirements for hospitals running clinical trials

The Chinese authorities are supplementing their current regulations around clinical trials with new mandates for the hospitals...

INC stock launches up almost 10% as CEO says business as usual
Exclusive interview

INC stock launches up almost 10% as CEO says business as usual

The IPO boom for CROs is kicking off with INC Research’s stock offering, which as of Friday...